• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    122.46 -1.47 (-1.19%)
    Official Closing Price Updated: 4:10 PM EST, Feb 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11,080,629
    Open 124.01
    Bid (Size) 122.53 (200)
    Ask (Size) 122.99 (400)
    Prev. Close 123.93
    Today's Range 122.26 - 125.14
    52wk Range 73.31 - 124.84
    Shares Outstanding 2,531,374,696
    Dividend Yield 2.78%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026
    From Merck & Co., Inc.
    Via Business Wire

    Performance

    YTD
    +15.0%
    +15.0%
    1 Month
    +14.0%
    +14.0%
    3 Month
    +15.9%
    +15.9%
    6 Month
    +44.1%
    +44.1%
    1 Year
    +34.2%
    +34.2%

    More News

    Read More
    News headline image
    Merck to Participate in the TD Cowen 46th Annual Health Care Conference
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Merck Evolves Human Health Operating Structure to Support Portfolio Execution
    From Merck & Co., Inc.
    Via Business Wire
    Merck & Co. Inc. (NYSE:MRK) Emerges as a Strong Dividend Contender Through Methodical Screening ↗
    Via Chartmill
    News headline image
    Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Could Merck Stock Quietly Help Turn Steady Dividends Into a Millionaire Retirement? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    ImmunityBio (IBRX): The Rise of Immunotherapy 2.0 and the Global Expansion of ANKTIVA
    Via Finterra
    Topics Lawsuit
    News headline image
    Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
    From Merck & Co., Inc. and Mayo Clinic
    Via Business Wire
    News headline image
    Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
    Via Finterra
    Topics Economy Intellectual Property
    News headline image
    Anktiva Vs Keytruda: ImmunityBio Exec Chair Slams FDA For Double Standards In Approvals ↗
    Via Stocktwits
    News headline image
    ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    8 Cheap Stocks to Buy in 2026 ↗
    Via The Motley Fool
    News headline image
    2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗
    Via The Motley Fool
    Topics Stocks
    News headline image
    Prediction: These Could Be the Best-Performing Value Stocks Through 2030 ↗
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
    Via MarketMinute
    Topics Earnings
    News headline image
    Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug? ↗
    Via The Motley Fool
    News headline image
    Dow Jones 267-Point Slide: Blue-Chip Leaders and the AI Reality Check
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    3 Mega-Cap Stocks for Long-Term Investors
    Via StockStory
    Topics Supply Chain
    News headline image
    The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
    Via Finterra
    Topics Artificial Intelligence Earnings Economy
    News headline image
    The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
    Via Finterra
    Topics Initial Public Offering Intellectual Property

    Frequently Asked Questions

    Is Merck & Co publicly traded?
    Yes, Merck & Co is publicly traded.
    What exchange does Merck & Co trade on?
    Merck & Co trades on the New York Stock Exchange
    What is the ticker symbol for Merck & Co?
    The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
    What is the current price of Merck & Co?
    The current price of Merck & Co is 122.46
    When was Merck & Co last traded?
    The last trade of Merck & Co was at 02/25/26 04:10 PM ET
    What is the market capitalization of Merck & Co?
    The market capitalization of Merck & Co is 309.99B
    How many shares of Merck & Co are outstanding?
    Merck & Co has 310B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.